J&J reports 12-month data for Varipulse PFA platform

​J&J has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its Varipulse PFA platform in first-time users.

The post J&J reports 12-month data for Varipulse PFA platform appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Vir Biotechnology doses first patient in Phase I VIR-5500 trial
MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority
Zebra Technologies and Aiva Health team up on nurse solutions
FDA issues complete response letter to Replimune’s RP1 for melanoma
BioNTech and DualityBio report positive data for trastuzumab pamirtecan

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us